ArticleArchives of medical science : AMS2025
Investigating the potential impact of sex hormones and adiponectin on the risk of liver fibrosis and cirrhosis: a Mendelian randomization study.
Article in Archives of medical science : AMS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Liver fibrosis is a reversible wound-healing response to acute or chronic liver injury. Liver cirrhosis is the advanced stage of liver fibrosis. This study explored the causal associations of sex hormones - estradiol, bioavailable testosterone, total testosterone, and sex hormone-binding globulin (SHBG) - and adiponectin with liver fibrosis, cirrhosis, and primary biliary cirrhosis (PBC). Material and methods: A two-sample Mendelian randomization (MR) study using publicly available data was performed. Causal estimates were calculated by the inverse variance weighted (IVW) method, and additional approaches such as MR-Egger, weighted median, simple mode, and weighted mode were used to complement the IVW approach. Sensitivity analysis was performed employing leave-one-out analysis. Results: The IVW analysis revealed a relationship between genetically predicted total testosterone levels and the likelihood of fibrosis and cirrhosis in females; odds ratio (OR) = 1.537, 95% confidence interval (CI): 1.082-2.182. There was a significant association between genetically predicted estradiol levels and an increased risk of liver fibrosis and cirrhosis (OR = 2.287, 95% CI: 1.403-3.727) and PBC (OR = 3.075, 95%CI: 1.306-7.240) in males. Our findings indicated that genetically predicted adiponectin was causally related to fibrosis and cirrhosis (OR = 1.608, 95% CI: 1.063-2.430) and PBC (OR = 2.631, 95% CI: 1.211-5.715). MR-Egger, weighted median, simple mode and weighted mode consistently yielded similar outcomes. Cochrane's Q test showed no heterogeneity in these instrumental variables, and there was no significant directional pleiotropy. Conclusions: There were positive causal associations of total testosterone with fibrosis and cirrhosis among females, and of estradiol levels with liver fibrosis and cirrhosis and PBC in males. Higher adiponectin could increase the risk of fibrosis and cirrhosis and PBC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.